Harnessing Open‐Source Solutions: Insights From the First Open Systems Pharmacology (<scp>OSP</scp>) Community Conference
In 2017, the free and open-source software Open Systems Pharmacology (OSP) was launched. Since then, OSP has evolved from a small community into a diverse network of stakeholders committed to advancing open-source solutions for model-informed drug development (MIDD). In this context, the first OSP Community Conference was hosted by Novartis in Basel, Switzerland, on October 7-8, 2024, which gathered over 100 attendees from more than 40 institutions. This perspective synthesizes key insights from the conference.
Authors
- Wilhelmus E. A. de Witte (ORCID: https://orcid.org/0000-0002-0840-3619)
- Siak‐Leng Choi (ORCID: https://orcid.org/0009-0001-9449-7606)
- Mariana Guimarães (ORCID: https://orcid.org/0009-0003-2896-8822)
- Julia Macente (ORCID: https://orcid.org/0000-0002-4452-5867)
- Tobias Kanacher (ORCID: https://orcid.org/0009-0002-0625-6616)
- Rolf Burghaus (ORCID: https://orcid.org/0000-0001-7843-427X)
- Kathleen M. Job (ORCID: https://orcid.org/0000-0003-0255-654X)
- Nina Nauwelaerts (ORCID: https://orcid.org/0000-0001-5301-6813)
- Stephan Schaller (ORCID: https://orcid.org/0000-0003-1046-7651)
- Donato Teutonico (ORCID: https://orcid.org/0000-0003-4931-410X)
- Sheila Annie Peters (ORCID: https://orcid.org/0000-0002-7436-8743)
- Thomas Wendl (ORCID: https://orcid.org/0000-0002-1153-7167)
- Salih Benamara (ORCID: https://orcid.org/0009-0007-0158-1336)
- Juri Solodenko (ORCID: https://orcid.org/0000-0001-6922-588X)
- Abdullah Hamadeh (ORCID: https://orcid.org/0000-0002-9419-1797)
- Lars Kuepfer (ORCID: https://orcid.org/0000-0002-8741-7786)
- Marylore Chenel (ORCID: https://orcid.org/0000-0001-7397-4007)
- Susana Proença (ORCID: https://orcid.org/0000-0003-1544-4686)
- Jan Schlender
- Alexander Staab
- Henrik Cordes (ORCID: https://orcid.org/0000-0002-0654-3386)
- Ibrahim Ince (ORCID: https://orcid.org/0000-0001-9036-7305)
- Masanobu Sato (ORCID: https://orcid.org/0000-0001-7108-0376)
- Pavel Balazki (ORCID: https://orcid.org/0000-0002-8199-9869)
- Annika R. P. Schneider (ORCID: https://orcid.org/0000-0003-1377-7102)
- Erik Sjögren (ORCID: https://orcid.org/0000-0003-4318-6039)
- André Dallmann (ORCID: https://orcid.org/0000-0003-1108-5719)
- Jörg Lippert (ORCID: https://orcid.org/0000-0002-0683-2874)
- Denise Feick (ORCID: https://orcid.org/0000-0002-4047-402X)
- Paul Vrenken (ORCID: https://orcid.org/0009-0007-2543-201X)
- Andreas Kovar (ORCID: https://orcid.org/0000-0002-1681-8312)
- Christoph Niederalt
Institutions
- Uppsala University (SE)
- Novartis (Switzerland) (CH)
- Centre National de la Recherche Scientifique (FR)
- Thorlabs (Germany) (DE)
- Boehringer Ingelheim (Germany) (DE)
- University of Waterloo (CA)
- Inserm (FR)
- National and Kapodistrian University of Athens (GR)
- Aix-Marseille Université (FR)
- University of Utah (US)
- Sanofi (France) (FR)
- Sanofi (Germany) (DE)
- Bayer (France) (FR)
- Bayer (Germany) (DE)
- RWTH Aachen University (DE)
- KU Leuven (BE)
Publication Details
- Journal
- CPT Pharmacometrics & Systems Pharmacology
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1002/psp4.70028
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission
- Fonds Wetenschappelijk Onderzoek
- Vlaamse regering
- National Institutes of Health
- National Institute of Child Health and Human Development
- Eunice Kennedy Shriver National Institute of Child Health and Human Development